Athira Pharma, Inc. (ATHA) Reports In-Line Q2 EPS

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.78), in-line with the analyst estimate of ($0.78).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• AeroVironment restates quarterly financials, citing $89M goodwill error